Application no. and date | 09747531.3 (espacenet) (Federated) (European Patent Register), 20090514 | Patent/reg. no. and date | DK/EP 2297100, 20121031 | Publication date | 20110323 | Priority no. and date | US 53722, 20080516 | EP pub. no. and date |
EP 2297100 20110323 | Effective date | | Applicant/owner | Eli Lilly & Company, Lilly Corporate Center
Indianapolis, IN 46285, US | Applicant ref. no. | P81205500DK00E | Inventor | JADHAV, Prabhakar, Kondaji, Eli Lilly and Company Lilly Corporate Center
Indianapolis, IN 46285, US, KRISHNAN, Venkatesh, Eli Lilly And Company Lilly Corporate Center
Indianapolis, IN 46285, US, KIM, Euibong, Jemes, Eli Lilly And Company Lilly Corporate Center
Indianapolis, IN 46285, US | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | Opponent | | IPC Class | A61K 31/403 (2006.01) , A61K 31/4439 (2006.01) , A61P 19/10 (2006.01) , A61P 21/00 (2006.01) , A61P 5/26 (2006.01) , C07D 209/94 (2006.01) , C07D 401/06 (2006.01) , C07D 403/06 (2006.01) | Title | TETRAHYDROCYCLOPENTA[B]INDOL-ANDROGENRECEPTOR-MODULATORER | Int. application no. | US2009043875 | Int. publication no. | WO2009140448 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|